Publications

Publications from OUS - Section for sarcoma and melanoma

337 publications found

Publications 2024

  1. Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C et al. (2024)
    Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
    Radiother Oncol, 195, 110273
    DOI 10.1016/j.radonc.2024.110273, PubMed 38588921
  2. Heramb-Aamot J, Mala T, Fauske L (2024)
    Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study
    Anticancer Res, 44 (2), 743-750
    DOI 10.21873/anticanres.16865, PubMed 38307550
  3. Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø (2024)
    Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study
    Acta Oncol, 63, 288-293
    DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
  4. Machak GN, Bruland ØS, Romanova TN, Kovalev AV (2024)
    Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
    J Bone Oncol, 45, 100596
    DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
  5. Os SS, Skipar K, Skovlund E, Hompland I, Hellebust TP, Guren MG, Lindemann K, Nakken ES (2024)
    Survival prediction in patients with gynecological cancer irradiated for brain metastases
    Acta Oncol, 63, 206-212
    DOI 10.2340/1651-226X.2023.34899, PubMed 38647023
  6. Riba M, Sala C, Culhane AC, Flobak Å, Patocs A, Boye K, Plevova K, Pospíšilová Š, Gandolfi G, Morelli MJ, Bucci G, Edsjö A, Lassen U, Al-Shahrour F, Lopez-Bigas N, Hovland R, Cuppen E, Valencia A, Poirel HA, Rosenquist R, Scollen S, Arenas Marquez J, Belien J, De Nicolo A, De Maria R et al. (2024)
    The 1+Million Genomes Minimal Dataset for Cancer
    Nat Genet, 56 (5), 733-736
    DOI 10.1038/s41588-024-01721-x, PubMed 38702538
  7. Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE (2024)
    Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
    Nat Commun, 15 (1), 2810
    DOI 10.1038/s41467-024-47031-y, PubMed 38561347

Publications 2023

  1. Berndsen M, Renberg S, Hølmebakk T, Hancke E, Puls F, Karlsson F, Stoldt S, Bjerkehagen B, Haglund de Flon F, Muth A, Papakonstantinou A, Boye K, Lindskog S (2023)
    Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
    Br J Surg, 110 (12), 1857-1862
    DOI 10.1093/bjs/znad309, PubMed 37758514
  2. Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
    Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
    Neurooncol Pract, 11 (1), 36-45
    DOI 10.1093/nop/npad063, PubMed 38222046
  3. Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
    Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
    JCO Precis Oncol, 7, e2200351
    DOI 10.1200/PO.22.00351, PubMed 36724411
  4. Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
    Editorial: Targeted alpha particle therapy in oncology
    Front Med (Lausanne), 10, 1165747
    DOI 10.3389/fmed.2023.1165747, PubMed 36960341
  5. Fauske L, Jebsen NL, Bondevik H, Bruland ØS (2023)
    Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
    Anticancer Res, 43 (5), 2031-2039
    DOI 10.21873/anticanres.16364, PubMed 37097689
  6. Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML et al. (2023)
    Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
    Eur J Cancer, 192, 113245
    DOI 10.1016/j.ejca.2023.113245, PubMed 37598656
  7. Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C (2023)
    Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
    Front Med (Lausanne), 10, 1058914
    DOI 10.3389/fmed.2023.1058914, PubMed 36844217
  8. Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
    Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
    BMJ Open, 13 (3), e070071
    DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
  9. Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA (2023)
    Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
    EBioMedicine, 97, 104829
    DOI 10.1016/j.ebiom.2023.104829, PubMed 37837931
  10. Janik AM, Terlecka A, Spałek MJ, Boye K, Szostakowski B, Chmiel P, Szumera-Ciećkiewicz A, Bobak K, Świtaj T, Rutkowski P, Czarnecka AM (2023)
    Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors
    Cancers (Basel), 15 (24)
    DOI 10.3390/cancers15245854, PubMed 38136399
  11. Jesse S, Kuhlmann L, Hildebrand LS, Magelssen H, Schmaus M, Timmermann B, Andres S, Fietkau R, Distel LV (2023)
    Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
    Cells, 12 (5)
    DOI 10.3390/cells12050820, PubMed 36899955
  12. Joensuu H, Wardelmann E, Eriksson M, Reichardt A, Hall KS, Schütte J, Cameron S, Hohenberger P, Sihto H, Jost PJ, Lindner LH, Bauer S, Nilsson B, Kallio R, Pesonen T, Reichardt P (2023)
    KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
    Clin Cancer Res, 29 (17), 3313-3319
    DOI 10.1158/1078-0432.CCR-22-3980, PubMed 37014660
  13. Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
    Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
    Front Med (Lausanne), 9, 1051825
    DOI 10.3389/fmed.2022.1051825, PubMed 36733936
  14. Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS (2023)
    First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
    Front Med (Lausanne), 10, 1070362
    DOI 10.3389/fmed.2023.1070362, PubMed 36936230
  15. Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
    Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
    Neuropathology, 43 (5), 385-390
    DOI 10.1111/neup.12895, PubMed 36754566
  16. Lloret I, Hompland I, Lobmaier IV, Sundseth J, Server A (2023)
    Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation
    Neuroradiol J, 19714009231212358 (in press)
    DOI 10.1177/19714009231212358, PubMed 37923348
  17. Mediå LM, Sigurdardottir S, Fauske L, Waehre A (2023)
    Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study
    Int J Qual Stud Health Well-being, 18 (1), 2204635
    DOI 10.1080/17482631.2023.2204635, PubMed 37092307
  18. Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
    Nat Commun, 14 (1), 3375
    DOI 10.1038/s41467-023-39097-x, PubMed 37291203
  19. Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2023)
    Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
    Mol Oncol, 17 (11), 2432-2450
    DOI 10.1002/1878-0261.13514, PubMed 37622176
  20. Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S (2023)
    Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.)
    Cancer, 129 (22), 3564-3573
    DOI 10.1002/cncr.34964, PubMed 37530385
  21. Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023)
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
    Ann Surg Oncol, 30 (12), 7602-7611
    DOI 10.1245/s10434-023-13964-9, PubMed 37481493
  22. Thorgersen EB, Asvall J, Schjalm C, McAdam KE, Bruland ØS, Larsen SG, Mollnes TE (2023)
    Effect of Intraperitoneal 224Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
    Technol Cancer Res Treat, 22, 15330338231192902
    DOI 10.1177/15330338231192902, PubMed 37574949
  23. Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC (2023)
    Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
    Radiother Oncol, 187, 109810
    DOI 10.1016/j.radonc.2023.109810, PubMed 37468069
  24. van de Wal D, Fauske L, Bruland ØS, Jones RL, Kasper B, Wilson R, van der Graaf WTA, Husson O (2023)
    Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
    Support Care Cancer, 31 (6), 352
    DOI 10.1007/s00520-023-07810-7, PubMed 37233829
  25. van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N, FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials (2023)
    A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
    Cancer Treat Rev, 120, 102625
    DOI 10.1016/j.ctrv.2023.102625, PubMed 37738712
  26. Wallander K, Öfverholm I, Boye K, Tsagkozis P, Papakonstantinou A, Lin Y, Haglund de Flon F (2023)
    Sarcoma care in the era of precision medicine
    J Intern Med, 294 (6), 690-707
    DOI 10.1111/joim.13717, PubMed 37643281
  27. Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS (2023)
    Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
    JAMA Netw Open, 6 (3), e234149
    DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452

Publications 2022

  1. Barnes DJ, Dutton P, Bruland Ø, Gelderblom H, Faleti A, Bühnemann C, van Maldegem A, Johnson H, Poulton L, Love S, Tiemeier G, van Beelen E, Herbschleb K, Haddon C, Billingham L, Bradley K, Ferrari S, Palmerini E, Picci P, Dirksen U, Strauss SJ, Hogendoorn PCW, Buddingh E, Blay JY, Cleton-Jansen AM et al. (2022)
    Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
    BMC Cancer, 22 (1), 629
    DOI 10.1186/s12885-022-09697-9, PubMed 35672690
  2. Boye K, Lobmaier I, Kobbeltvedt MR, Thorkildsen J, Taksdal I, Bjerkehagen B, Bruland ØS, Zaikova O, Sundby Hall K, Hompland I (2022)
    Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
    Acta Oncol, 61 (7), 793-800
    DOI 10.1080/0284186X.2022.2082259, PubMed 35698755
  3. Fauske L, Wærstad PH, Hompland I, Bruland ØS (2022)
    Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
    Anticancer Res, 42 (2), 955-963
    DOI 10.21873/anticanres.15555, PubMed 35093895
  4. Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H et al. (2022)
    Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
    Br J Cancer, 127 (10), 1793-1798
    DOI 10.1038/s41416-022-01959-4, PubMed 36030294
  5. Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
    Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
    Oncotarget, 13, 508-517
    DOI 10.18632/oncotarget.28209, PubMed 35284037
  6. Mediå LM, Fauske L, Sigurdardottir S, Feragen KJB, Heggeli C, Wæhre A (2022)
    'It was Supposed to be a Secret': a study of disclosure and stigma as experienced by adults with differences of sex development
    Health Psychol Behav Med, 10 (1), 579-595
    DOI 10.1080/21642850.2022.2102018, PubMed 35898596
  7. Pulkka OP, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, Eriksson M, Hall KS, Wardelmann E, Nilsson B, Sihto H, Joensuu H (2022)
    Fibrinogen-like protein 2 in gastrointestinal stromal tumour
    J Cell Mol Med, 26 (4), 1083-1094
    DOI 10.1111/jcmm.17163, PubMed 35029030
  8. Schmid MP, Harrabi S, Herfarth K, Bruland ØS, Welzel T, Haberer T, Ellerbrock M, Debus J, Uhl M, Seidensaal K (2022)
    Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes
    Cancers (Basel), 14 (24)
    DOI 10.3390/cancers14246045, PubMed 36551530
  9. Seidensaal K, Dostal M, Liermann J, Adeberg S, Weykamp F, Schmid MP, Freudlsperger C, Hoffmann J, Hompland I, Herfarth K, Debus J, Harrabi SB (2022)
    Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
    Front Oncol, 12, 927399
    DOI 10.3389/fonc.2022.927399, PubMed 36212490
  10. Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL et al. (2022)
    Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
    Cancer Treat Rev, 112, 102491
    DOI 10.1016/j.ctrv.2022.102491, PubMed 36502615
  11. Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
    Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001
    Cancers (Basel), 14 (11)
    DOI 10.3390/cancers14112784, PubMed 35681766
  12. Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
    Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
    Front Med (Lausanne), 9, 1058863
    DOI 10.3389/fmed.2022.1058863, PubMed 36507500

Publications 2021

  1. Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
    Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Cancer Immunol Immunother, 70 (9), 2617-2624
    DOI 10.1007/s00262-021-02876-w, PubMed 33580363
  2. Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F et al. (2021)
    Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 33 (1), 20-33
    DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
  3. Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE (2021)
    Does the Lightning Process Training Programme Reduce Chronic Fatigue in Adolescent and Young Adult Cancer Survivors? A Mixed-Methods Pilot Study
    Cancers (Basel), 13 (16)
    DOI 10.3390/cancers13164076, PubMed 34439229
  4. Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
    Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
    Pathology, 53 (6), 713-719
    DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
  5. Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
    Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
    Eur J Cancer, 151, 150-158
    DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
  6. Hølmebakk T, Boye K (2021)
    ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
    Ann Surg Oncol, 28 (11), 6846-6847
    DOI 10.1245/s10434-021-09608-5, PubMed 33687615
  7. Hølmebakk T, Boye K (2021)
    Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
    Ann Surg Oncol, 28 (Suppl 3), 873
    DOI 10.1245/s10434-021-09939-3, PubMed 33829360
  8. Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
    Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
    Ann Surg Oncol, 28 (11), 6837-6845
    DOI 10.1245/s10434-021-09605-8, PubMed 33651216
  9. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
    Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Cancers (Basel), 13 (4)
    DOI 10.3390/cancers13040779, PubMed 33668474
  10. Kerboeuf M, Koppang EO, Haaland AH, Lingaas F, Bruland ØS, Teige J, Moe L (2021)
    Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
    Acta Vet Scand, 63 (1), 41
    DOI 10.1186/s13028-021-00608-9, PubMed 34732227
  11. Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
    Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
    JAMA Oncol, 7 (1), e205865
    DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
  12. Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
    Metastases in locally advanced rectal cancer undergoing curatively intended treatment
    Eur J Surg Oncol, 47 (9), 2377-2383
    DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
  13. Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
    Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
    Clin Transl Radiat Oncol, 28, 39-47
    DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
  14. Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
    Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
    PLoS One, 16 (3), e0248133
    DOI 10.1371/journal.pone.0248133, PubMed 33662039
  15. Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
    Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
    Nat Commun, 12 (1), 3230
    DOI 10.1038/s41467-021-23445-w, PubMed 34050156
  16. Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
    Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
    Acta Radiol, 63 (8), 995-1004
    DOI 10.1177/02841851211027389, PubMed 34171968
  17. Spasojevic M, Mariathasan AB, Frich L, Bruland ØS, Larsen SG, Stoldt S (2021)
    [Cancer therapy with isolated limb perfusion]
    Tidsskr Nor Laegeforen, 141 (2021-12)
    DOI 10.4045/tidsskr.21.0194, PubMed 34505491
  18. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
  19. Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
    Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
    Acta Radiol Open, 10 (7), 20584601211036550
    DOI 10.1177/20584601211036550, PubMed 34377543
  20. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
  21. van Eck I, den Hollander D, Lidington E, Hentschel L, Eichler M, Salah S, Singer S, Pinto M, Fauske L, Fiore M, Nixon I, Constantinidou A, Desar IME, Bonenkamp JJ, van Houdt WJ, Reuvers MJP, Haas RLM, Bruland ØS, Kasper B, van der Graaf WTA, Husson O (2021)
    Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
    J Clin Med, 10 (22)
    DOI 10.3390/jcm10225334, PubMed 34830615
  22. Våde L, Hompland I, Fauske L (2021)
    Exploring Mentorship as a Novel Approach to Improving Quality of Life in Sarcoma Survivors: A Qualitative Pilot Study
    Sarcoma, 2021, 2042785
    DOI 10.1155/2021/2042785, PubMed 34421328

Publications 2020

  1. Dagenborg VJ, Marshall SE, Yaqub S, Grzyb K, Boye K, Lund-Iversen M, Høye E, Berstad AE, Fretland ÅA, Edwin B, Ree AH, Flatmark K (2020)
    Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
    Cancer Biol Ther, 21 (5), 432-440
    DOI 10.1080/15384047.2020.1721252, PubMed 32098573
  2. Fauske L, Hompland I, Lorem G, Hall KS, Bondevik H (2020)
    Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission
    Sarcoma, 2020, 1814394
    DOI 10.1155/2020/1814394, PubMed 33082706
  3. Fleten KG, Lund-Andersen C, Waagene S, Abrahamsen TW, Mørch Y, Boye K, Torgunrud A, Flatmark K (2020)
    Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
    Transl Oncol, 13 (8), 100793
    DOI 10.1016/j.tranon.2020.100793, PubMed 32447231
  4. Georgiesh T, Boye K, Bjerkehagen B (2020)
    A novel risk score to predict early and late recurrence in solitary fibrous tumour
    Histopathology, 77 (1), 123-132
    DOI 10.1111/his.14078, PubMed 31991494
  5. Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M (2020)
    Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
    Clin Sarcoma Res, 10 (1), 22
    DOI 10.1186/s13569-020-00145-5, PubMed 33292545
  6. Hamre CFB, Kvammen EMH, Vinge LE, Skeie AT, Hompland I (2020)
    Sarcoma of the heart
    Tidsskr. Nor. Laegeforen., 140 (6), 582-583
  7. Hompland I, Fauske L, Lorem GF, Bruland ØS (2020)
    Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
    Clin Sarcoma Res, 10, 2
    DOI 10.1186/s13569-019-0124-3, PubMed 31969978
  8. Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C (2020)
    The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy
    Lancet Child Adolesc Health, 4 (11), 846-852
    DOI 10.1016/S2352-4642(20)30183-8, PubMed 33068550
  9. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
    The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
    Front Oncol, 10, 1402
    DOI 10.3389/fonc.2020.01402, PubMed 32850452
  10. Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ (2020)
    Prospects for NK Cell Therapy of Sarcoma
    Cancers (Basel), 12 (12)
    DOI 10.3390/cancers12123719, PubMed 33322371
  11. Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
    Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples
    Appl Radiat Isot, 166, 109362
    DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
  12. Palmerini E, Leithner A, Windhager R, Gosheger G, Boye K, Laitinen M, Hardes J, Traub F, Jutte P, Willegger M, Casanova J, Setola E, Righi A, Picci P, Donati DM, Ferrari S (2020)
    Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
    Sci Rep, 10 (1), 10853
    DOI 10.1038/s41598-020-66579-5, PubMed 32616718
  13. Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020)
    Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
    Acta Oncol, 59 (7), 733-740
    DOI 10.1080/0284186X.2020.1742377, PubMed 32208873
  14. Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
    In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
    Curr Radiopharm, 13 (2), 130-141
    DOI 10.2174/1874471013666200511000532, PubMed 32389119
  15. Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
    Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer
    J Labelled Comp Radiopharm, 63 (3), 129-143
    DOI 10.1002/jlcr.3825, PubMed 31919866

Publications 2019

  1. Berner K, Bruland ØS (2019)
    Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas
    Anticancer Res, 39 (5), 2459-2466
    DOI 10.21873/anticanres.13365, PubMed 31092440
  2. Fauske L, Bondevik H, Ahlberg K, Bjørndal A (2019)
    Identifying bone sarcoma survivors facing psychosocial challenges. A study of trajectories following treatment
    Eur J Cancer Care (Engl), 28 (5), e13119
    DOI 10.1111/ecc.13119, PubMed 31184795
  3. Fauske L, Hompland I, Lorem G, Bondevik H, Bruland ØS (2019)
    Perspectives on treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study
    Clin Sarcoma Res, 9, 6
    DOI 10.1186/s13569-019-0116-3, PubMed 31061697
  4. Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G et al. (2019)
    Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
    Lancet Oncol, 20 (3), e155-e166
    DOI 10.1016/S1470-2045(19)30034-8, PubMed 30842059
  5. Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
    Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
    Ann Surg Oncol, 26 (13), 4730-4736
    DOI 10.1245/s10434-019-07813-x, PubMed 31520212
  6. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
    Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
    J Glob Oncol, 5, 1-10
    DOI 10.1200/JGO.19.00015, PubMed 30917070
  7. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S (2019)
    Treating osteosarcoma with CAR T cells
    Scand J Immunol, 89 (3), e12741
    DOI 10.1111/sji.12741, PubMed 30549299
  8. Namløs HM, Boye K, Meza-Zepeda LA (2019)
    Cell-free DNA in blood as a noninvasive insight into the sarcoma genome
    Mol Aspects Med, 72, 100827
    DOI 10.1016/j.mam.2019.10.004, PubMed 31703948
  9. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
  10. Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland HK, Børge Johannesen T, Viset T, Norum OJ, Bruland Ø, Zaikova O (2019)
    Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort
    Acta Oncol, 58 (3), 273-282
    DOI 10.1080/0284186X.2018.1554260, PubMed 30632866

Publications 2018

  1. Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens GO, SIOPE BTG Radiotherapy Group (2018)
    SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
    Radiother Oncol, 128 (2), 192-197
    DOI 10.1016/j.radonc.2018.04.016, PubMed 29729847
  2. Berner K, Johannesen TB, Hall KS, Bruland ØS (2018)
    Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study
    J Bone Oncol, 14, 002-2
    DOI 10.1016/j.jbo.2018.11.002, PubMed 30568874
  3. Berner K, Zaikova O, Johannesen TB, Hall KS, Bruland ØS (2018)
    Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
    J Surg Oncol, 118 (1), 246-247
    DOI 10.1002/jso.25137, PubMed 30208205
  4. Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
    Genotype and risk of tumour rupture in gastrointestinal stromal tumour
    Br J Surg, 105 (2), e169-e175
    DOI 10.1002/bjs.10743, PubMed 29341147
  5. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P et al. (2018)
    Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
    JAMA Oncol, 4 (9), e180219
    DOI 10.1001/jamaoncol.2018.0219, PubMed 29800950
  6. Heinrich D, Bruland Ø, Guise TA, Suzuki H, Sartor O (2018)
    Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
    Future Oncol, 14 (24), 2543-2556
    DOI 10.2217/fon-2018-0087, PubMed 29925281
  7. Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P (2018)
    Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
    J Bone Oncol, 14, 100216
    DOI 10.1016/j.jbo.2018.100216, PubMed 30666289
  8. Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
    Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
    Br J Surg, 106 (4), 419-426
    DOI 10.1002/bjs.11027, PubMed 30507040
  9. Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
    Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
    Ann Surg Oncol, 25 (5), 1133-1139
    DOI 10.1245/s10434-018-6353-5, PubMed 29435684
  10. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2018)
    Added value of F-18-FDG PET-CT in staging of Ewing sarcoma in children and young adults
    Eur. J. Hybrid Imag., 2 (1), 13
    DOI 10.1186/s41824-018-0031-5
  11. Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K (2018)
    Pazopanib in relapsed osteosarcoma patients: report on 15 cases
    Acta Oncol, 58 (1), 124-128
    DOI 10.1080/0284186X.2018.1503714, PubMed 30207179
  12. Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA (2018)
    Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor
    Mol Cancer Ther, 17 (11), 2473-2480
    DOI 10.1158/1535-7163.MCT-18-0174, PubMed 30097488
  13. Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME et al. (2018)
    Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)
    Acta Oncol, 57 (9), 1240-1249
    DOI 10.1080/0284186X.2018.1465588, PubMed 29698060
  14. Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M (2018)
    Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
    Eur J Cancer, 99, 78-85
    DOI 10.1016/j.ejca.2018.05.011, PubMed 29929092
  15. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH (2018)
    Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer
    Transl Oncol, 11 (2), 259-267
    DOI 10.1016/j.tranon.2017.12.011, PubMed 29413758
  16. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH (2018)
    Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice
    J Labelled Comp Radiopharm, 61 (6), 472-486
    DOI 10.1002/jlcr.3610, PubMed 29380410

Publications 2017

  1. Boye K, Jebsen NL, Zaikova O, Knobel H, Løndalen AM, Trovik CS, Monge OR, Hall KS (2017)
    Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort
    Acta Oncol, 56 (3), 479-483
    DOI 10.1080/0284186X.2016.1278305, PubMed 28105885
  2. Egeland EV, Boye K, Park D, Synnestvedt M, Sauer T, Oslo Breast Cancer Consortium (OSBREAC), Naume B, Borgen E, Mælandsmo GM (2017)
    Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
    Breast Cancer Res Treat, 162 (1), 127-137
    DOI 10.1007/s10549-016-4096-1, PubMed 28058579
  3. Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
    Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
    Acta Oncol, 56 (10), 1317-1323
    DOI 10.1080/0284186X.2017.1330555, PubMed 28557540
  4. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
    Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
    BMC Cancer, 17 (1), 29
    DOI 10.1186/s12885-016-2992-8, PubMed 28061772
  5. Parker CC, Coleman RE, Sartor O, Vogelzang NJ, Bottomley D, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Bruland ØS et al. (2017)
    Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
    Eur Urol, 73 (3), 427-435
    DOI 10.1016/j.eururo.2017.06.021, PubMed 28705540
  6. Pulkka OP, Nilsson B, Sarlomo-Rikala M, Reichardt P, Eriksson M, Hall KS, Wardelmann E, Vehtari A, Joensuu H, Sihto H (2017)
    SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
    Br J Cancer, 116 (9), 1195-1202
    DOI 10.1038/bjc.2017.82, PubMed 28334729
  7. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
    Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
    ESMO Open, 2 (2), e000158
    DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
  8. Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C (2017)
    An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
    Ann Oncol, 28 (5), 1090-1097
    DOI 10.1093/annonc/mdx044, PubMed 28453701
  9. Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A (2017)
    Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
    Oncologist, 23 (1), 62-70
    DOI 10.1634/theoncologist.2017-0161, PubMed 28754721

Publications 2016

  1. Barøy T, Chilamakuri CS, Lorenz S, Sun J, Bruland ØS, Myklebost O, Meza-Zepeda LA (2016)
    Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
    PLoS One, 11 (9), e0163859
    DOI 10.1371/journal.pone.0163859, PubMed 27685995
  2. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
    Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
    Cancer Med, 5 (8), 1840-9
    DOI 10.1002/cam4.766, PubMed 27273130
  3. Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K (2016)
    Expression and clinical significance of Wee1 in colorectal cancer
    Tumour Biol, 37 (9), 12133-12140
    DOI 10.1007/s13277-016-5081-3, PubMed 27220319
  4. Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K (2016)
    Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
    Clin Sarcoma Res, 6, 21
    DOI 10.1186/s13569-016-0062-2, PubMed 27999655
  5. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2016)
    Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012
    Pediatr Radiol, 47 (1), 82-88
    DOI 10.1007/s00247-016-3720-x, PubMed 27815616
  6. König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR (2016)
    Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years
    Neurosurg Rev, 40 (3), 449-460
    DOI 10.1007/s10143-016-0802-z, PubMed 27858303
  7. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS et al. (2016)
    Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
    Lancet Oncol, 17 (10), 1396-1408
    DOI 10.1016/S1470-2045(16)30214-5, PubMed 27569442
  8. Parker C, Finkelstein SE, Michalski JM, O'Sullivan JM, Bruland Ø, Vogelzang NJ, Coleman RE, Nilsson S, Sartor O, Li R, Seger MA, Bottomley D (2016)
    Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial
    Eur Urol, 70 (5), 875-883
    DOI 10.1016/j.eururo.2016.06.002, PubMed 27344296
  9. Rud AK, Boye K, Fodstad Ø, Juell S, Jørgensen LH, Solberg S, Helland Å, Brustugun OT, Mælandsmo GM (2016)
    Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
    Diagn Pathol, 11 (1), 50
    DOI 10.1186/s13000-016-0504-4, PubMed 27316334
  10. Varghese M, Bruland O, Wiedswang AM, Lobmaier I, Røsok B, Benjamin RS, Hall KS (2016)
    Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature
    Clin Sarcoma Res, 6, 2
    DOI 10.1186/s13569-016-0042-6, PubMed 26913180
  11. Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH (2016)
    Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
    PLoS One, 11 (10), e0165382
    DOI 10.1371/journal.pone.0165382, PubMed 27776176

Publications 2015

  1. Anfinsen KP, Grotmol T, Bruland OS, Cathrine T, Jonasdottir TJ (2015)
    Corrigendum to "Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence" [Prev. Vet. Med. 119 (2015) 48-53]
    Prev Vet Med, 120 (2), 252
    DOI 10.1016/j.prevetmed.2015.03.015, PubMed 31159133
  2. Anfinsen KP, Grotmol T, Bruland OS, Trangerud C, Jonasdottir TJ (2015)
    Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence
    Prev Vet Med, 119 (1-2), 48-53
    DOI 10.1016/j.prevetmed.2015.02.003, PubMed 25732913
  3. Berner K, Bjerkehagen B, Bruland ØS, Berner A (2015)
    Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature
    Anticancer Res, 35 (4), 2129-40
    PubMed 25862869
  4. Berner K, Hall KS, Monge OR, Weedon-Fekjær H, Zaikova O, Bruland ØS (2015)
    Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient
    Sarcoma, 2015, 516843
    DOI 10.1155/2015/516843, PubMed 25784831
  5. Berner K, Johannesen TB, Bruland ØS (2015)
    Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009
    Sarcoma, 2015, 917679
    DOI 10.1155/2015/917679, PubMed 26412976
  6. Egeland EV, Boye K, Pettersen SJ, Haugen MH, Øyjord T, Malerød L, Flatmark K, Mælandsmo GM (2015)
    Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
    Clin Exp Metastasis, 32 (8), 755-67
    DOI 10.1007/s10585-015-9742-1, PubMed 26349943
  7. Fauske L, Bondevik H, Bruland ØS, Ozakinci G (2015)
    Negative and Positive Consequences of Cancer Treatment Experienced by Long-term Osteosarcoma Survivors: A Qualitative Study
    Anticancer Res, 35 (11), 6081-90
    PubMed 26504033
  8. Fauske L, Bruland OS, Grov EK, Bondevik H (2015)
    Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities
    Sarcoma, 2015, 484196
    DOI 10.1155/2015/484196, PubMed 25949211
  9. Fauske L, Lorem G, Grov EK, Bondevik H (2015)
    Changes in the body image of bone sarcoma survivors following surgical treatment--A qualitative study
    J Surg Oncol, 113 (2), 229-34
    DOI 10.1002/jso.24138, PubMed 26714610
  10. Ferrari S, Luksch R, Hall KS, Fagioli F, Prete A, Tamburini A, Tienghi A, DiGirolamo S, Paioli A, Abate ME, Podda M, Cammelli S, Eriksson M, Brach del Prever A (2015)
    Post-relapse survival in patients with Ewing sarcoma
    Pediatr Blood Cancer, 62 (6), 994-9
    DOI 10.1002/pbc.25388, PubMed 25585917
  11. Hompland I, Bruland ØS (2015)
    Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?
    Anticancer Res, 35 (11), 5759-65
    PubMed 26503996
  12. Hompland I, Rizvi SM, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mørk NJ, Hall KS (2015)
    [A boy with a wound on his finger that would not heal]
    Tidsskr Nor Laegeforen, 135 (5), 445-8
    DOI 10.4045/tidsskr.14.0759, PubMed 25761032
  13. Hompland I, Rizvi SMH, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mork NJ, Hall KS (2015)
    A boy with a wound on his finger that would not heal
    Tidsskr. Nor. Laegeforen., 135 (5), 444-447
  14. Humm JL, Sartor O, Parker C, Bruland OS, Macklis R (2015)
    Radium-223 in the treatment of osteoblastic metastases: a critical clinical review
    Int J Radiat Oncol Biol Phys, 91 (5), 898-906
    DOI 10.1016/j.ijrobp.2014.12.061, PubMed 25832684
  15. Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM (2015)
    F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study
    Clin Physiol Funct Imaging, 36 (6), 441-446
    DOI 10.1111/cpf.12247, PubMed 26039107
  16. Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
    Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
    Scand J Public Health, 43 (3), 324-30
    DOI 10.1177/1403494815572206, PubMed 25740614
  17. Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
    Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
    Anticancer Res, 35 (2), 1171-80
    PubMed 25667508
  18. Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015)
    Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
    Mol Oncol, 9 (6), 1129-39
    DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404
  19. Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM (2015)
    Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
    Cancer Immunol Immunother, 64 (6), 769-76
    DOI 10.1007/s00262-015-1686-4, PubMed 25832001

Publications 2014

  1. Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ, Bruland ØS (2014)
    Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma
    Acta Oncol, 54 (1), 25-33
    DOI 10.3109/0284186X.2014.923934, PubMed 24957555
  2. Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K (2014)
    High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting
    Eur J Cancer, 51 (1), 9-17
    DOI 10.1016/j.ejca.2014.10.020, PubMed 25466510
  3. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø (2014)
    B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
    BMC Cancer, 14, 602
    DOI 10.1186/1471-2407-14-602, PubMed 25139714
  4. Joensuu H, Eriksson M, Hall KS, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman KV, Leinonen M, DeMatteo RP, Reichardt P (2014)
    Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
    Cancer, 120 (15), 2325-33
    DOI 10.1002/cncr.28669, PubMed 24737415
  5. Ohnstad HO, Bruland OS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, Jørgensen LH, Hall KS (2014)
    Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?
    Acta Oncol, 53 (9), 1180-7
    DOI 10.3109/0284186X.2014.899433, PubMed 24697744
  6. Panagopoulos I, Bjerkehagen B, Gorunova L, Berner JM, Boye K, Heim S (2014)
    Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification
    Int J Oncol, 45 (5), 1829-36
    DOI 10.3892/ijo.2014.2605, PubMed 25176350
  7. Panagopoulos I, Gorunova L, Bjerkehagen B, Boye K, Heim S (2014)
    Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
    Oncol Rep, 32 (1), 40-4
    DOI 10.3892/or.2014.3180, PubMed 24839999
  8. Repetto-Llamazares A, Abbas N, Bruland ØS, Dahle J, Larsen RH (2014)
    Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors
    Anticancer Res, 34 (7), 3263-9
    PubMed 24982330
  9. Repetto-Llamazares AH, Larsen RH, Giusti AM, Riccardi E, Bruland ØS, Selbo PK, Dahle J (2014)
    177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice
    PLoS One, 9 (7), e103070
    DOI 10.1371/journal.pone.0103070, PubMed 25068508
  10. Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C (2014)
    Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
    Lancet Oncol, 15 (7), 738-46
    DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273
  11. Switlyk MD, Bruland ØS, Skjeldal S, Hald JK, Seierstad T, Zaikova O (2014)
    Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI
    J Bone Oncol, 3 (1), 5-9
    DOI 10.1016/j.jbo.2014.02.003, PubMed 26909292

Publications 2013

  1. Abbas N, Heyerdahl H, Bruland ØS, Brevik EM, Dahle J (2013)
    Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 positive SKBR-3 xenografts
    Curr Radiopharm, 6 (2), 78-86
    DOI 10.2174/18744710113069990017, PubMed 23551110
  2. Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Bruland ØS, Smeland S, Johannesen TB, Fosså SD (2013)
    Incidence and mortality of second sarcomas - a population-based study
    Eur J Cancer, 49 (15), 3292-302
    DOI 10.1016/j.ejca.2013.05.017, PubMed 23787025
  3. Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS (2013)
    High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study
    Pediatr Blood Cancer, 61 (5), 840-5
    DOI 10.1002/pbc.24868, PubMed 24254749
  4. Dahle J, Repetto-Llamazares AH, Mollatt CS, Melhus KB, Bruland OS, Kolstad A, Larsen RH (2013)
    Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma
    Anticancer Res, 33 (1), 85-95
    PubMed 23267131
  5. Friedman R, Boye K, Flatmark K (2013)
    Molecular modelling and simulations in cancer research
    Biochim Biophys Acta, 1836 (1), 1-14
    DOI 10.1016/j.bbcan.2013.02.001, PubMed 23416097
  6. Heyerdahl H, Abbas N, Sponheim K, Mollatt C, Bruland Ø, Dahle J (2013)
    Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice
    Curr Radiopharm, 6 (2), 106-16
    DOI 10.2174/18744710113069990018, PubMed 23551111
  7. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
    Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
    Neuro Oncol, 16 (2), 320-2
    DOI 10.1093/neuonc/not230, PubMed 24311631
  8. Jebsen NL, Engellau J, Engström K, Bauer HC, Monge OR, Muren LP, Eide GE, Trovik CS, Bruland OS (2013)
    Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall
    Int J Radiat Oncol Biol Phys, 86 (5), 949-55
    DOI 10.1016/j.ijrobp.2013.04.015, PubMed 23725998
  9. Lagunova Z, Porojnicu AC, Aksnes L, Holick MF, Iani V, Bruland OS, Moan J (2013)
    Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial
    Br J Dermatol, 169 (2), 434-40
    DOI 10.1111/bjd.12349, PubMed 23551243
  10. Lia K, Bruland ØS, Randem HL, Aksnes LH, Poulsen JP, Taksdal I, Sundby Hall K (2013)
    Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma
    J Bone Oncol, 2 (4), 174-9
    DOI 10.1016/j.jbo.2013.09.002, PubMed 26909289
  11. Mikalsen LT, Dhakal HP, Bruland ØS, Naume B, Borgen E, Nesland JM, Olsen DR (2013)
    The clinical impact of mean vessel size and solidity in breast carcinoma patients
    PLoS One, 8 (10), e75954
    DOI 10.1371/journal.pone.0075954, PubMed 24146798
  12. Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG et al. (2013)
    Alpha emitter radium-223 and survival in metastatic prostate cancer
    N Engl J Med, 369 (3), 213-23
    DOI 10.1056/NEJMoa1213755, PubMed 23863050
  13. Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T (2013)
    Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
    Acta Oncol, 53 (1), 143-8
    DOI 10.3109/0284186X.2013.798428, PubMed 23710697
  14. Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
    Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
    Acta Oncol, 52 (4), 776-82
    DOI 10.3109/0284186X.2013.770920, PubMed 23480638
  15. Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM (2013)
    Osteopontin is a prognostic biomarker in non-small cell lung cancer
    BMC Cancer, 13, 540
    DOI 10.1186/1471-2407-13-540, PubMed 24215488
  16. Rusten E, Rødal J, Bruland Ø, Malinen E (2013)
    Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy
    Acta Oncol, 52 (7), 1378-83
    DOI 10.3109/0284186X.2013.813071, PubMed 23981046

Publications 2012

  1. Abbas N, Bruland ØS, Brevik EM, Dahle J (2012)
    Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts
    Nucl Med Commun, 33 (8), 838-47
    DOI 10.1097/MNM.0b013e328354df7c, PubMed 22643311
  2. Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
    High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
    Br J Clin Pharmacol, 73 (1), 106-14
    DOI 10.1111/j.1365-2125.2011.04054.x, PubMed 21707700
  3. Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D (2012)
    Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?
    Int J Radiat Oncol Biol Phys, 84 (3), 572-80
    DOI 10.1016/j.ijrobp.2012.01.062, PubMed 22520481
  4. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O (2012)
    B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
    Int J Cancer, 131 (11), 2528-36
    DOI 10.1002/ijc.27566, PubMed 22473715
  5. Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA (2012)
    Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
    Neuro Oncol, 15 (2), 135-47
    DOI 10.1093/neuonc/nos287, PubMed 23161774
  6. Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
    Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
    Melanoma Res, 22 (6), 460-5
    DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822
  7. Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
    Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
    Sarcoma, 2012, 639038
    DOI 10.1155/2012/639038, PubMed 22518090
  8. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, O'Bryan-Tear CG, Thuresson M, Bolstad B, Bruland ØS (2012)
    Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases
    Clin Genitourin Cancer, 11 (1), 20-6
    DOI 10.1016/j.clgc.2012.07.002, PubMed 23021204
  9. Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS (2012)
    A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
    Eur J Cancer, 48 (5), 678-86
    DOI 10.1016/j.ejca.2011.12.023, PubMed 22341993
  10. Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K (2012)
    Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
    BMC Cancer, 12, 333
    DOI 10.1186/1471-2407-12-333, PubMed 22853000
  11. Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
    Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
    Acta Oncol, 52 (6), 1160-7
    DOI 10.3109/0284186X.2012.728713, PubMed 23198721
  12. Sartor O, Hoskin P, Bruland OS (2012)
    Targeted radio-nuclide therapy of skeletal metastases
    Cancer Treat Rev, 39 (1), 18-26
    DOI 10.1016/j.ctrv.2012.03.006, PubMed 22534284
  13. Schee K, Boye K, Abrahamsen TW, Fodstad Ø, Flatmark K (2012)
    Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
    BMC Cancer, 12, 505
    DOI 10.1186/1471-2407-12-505, PubMed 23121918
  14. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients (vol 33, pg 73, 2012)
    Tumor Biol., 33 (4), 1263-1264
    DOI 10.1007/s13277-012-0407-2

Publications 2011

  1. Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
    Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
    EJNMMI Res, 1 (1), 18
    DOI 10.1186/2191-219X-1-18, PubMed 22214432
  2. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011)
    Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005)
    Cancer Epidemiol Biomarkers Prev, 20 (8), 1770-7
    DOI 10.1158/1055-9965.EPI-11-0136, PubMed 21724855
  3. Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ (2011)
    Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway
    Can J Vet Res, 75 (3), 209-15
    PubMed 22210997
  4. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM (2011)
    Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis
    Int J Cancer, 129 (4), 780-90
    DOI 10.1002/ijc.25735, PubMed 20957651
  5. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
    Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
    Curr Radiopharm, 4 (4), 321-8
    DOI 10.2174/1874471011104040321, PubMed 22202154
  6. Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR (2011)
    Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections
    Anticancer Res, 31 (12), 4053-60
    PubMed 22199261
  7. Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
    Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
    Mol Imaging Biol, 13 (6), 1234-40
    DOI 10.1007/s11307-010-0464-0, PubMed 21161686
  8. Sartor O, Bruland O (2011)
    Stromal targeted therapies in prostate and renal cancer: new concepts and knowledge
    Clin Genitourin Cancer, 9 (1), 1-2
    DOI 10.1016/j.clgc.2011.08.001, PubMed 21925102
  9. Sartor O, Goeckeler W, Bruland O (2011)
    Stromal targeted therapy in bone metastatic prostate cancer: promise delivered
    Asian J Androl, 13 (6), 783-4
    DOI 10.1038/aja.2011.120, PubMed 21857688
  10. Schee K, Flatmark K, Holm R, Boye K, Paus E (2011)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
    Tumour Biol, 33 (1), 73-83
    DOI 10.1007/s13277-011-0247-5, PubMed 22006279
  11. Smeland S, Bruland OS, Hjorth L, Brosjö O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Björk O, Alvegaard TA (2011)
    Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
    Acta Orthop, 82 (2), 211-6
    DOI 10.3109/17453674.2011.566141, PubMed 21434784
  12. Stensvold E, Magelssen H, Oskam IC (2011)
    Fertility-preserving measures for girls and young women with cancer
    Tidsskr Nor Laegeforen, 131 (15), 1429-32
    DOI 10.4045/tidsskr.11.0126, PubMed 21844944
  13. Stensvold E, Magelssen H, Oskam IC (2011)
    Fertility-preserving measures for boys and young men with cancer
    Tidsskr Nor Laegeforen, 131 (15), 1433-5
    DOI 10.4045/tidsskr.11.0426, PubMed 21844945
  14. Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S (2011)
    Radiotherapy or surgery for spine metastases?
    Acta Orthop, 82 (3), 365-71
    DOI 10.3109/17453674.2011.566142, PubMed 21434789

Publications 2010

  1. Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA (2010)
    Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
    J Clin Oncol, 28 (9), 1573-82
    DOI 10.1200/JCO.2009.24.8989, PubMed 20159821
  2. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
    Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
    J Photochem Photobiol B, 101 (2), 174-8
    DOI 10.1016/j.jphotobiol.2010.04.002, PubMed 20430639
  3. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
    CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
    Strahlenther Onkol, 186 (3), 163-8
    DOI 10.1007/s00066-010-2040-6, PubMed 20165821
  4. Grotterød I, Maelandsmo GM, Boye K (2010)
    Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB
    BMC Cancer, 10, 241
    DOI 10.1186/1471-2407-10-241, PubMed 20507646
  5. Jebsen NL, Bruland ØS, Eriksson M, Engellau J, Turesson I, Folin A, Trovik CS, Hall KS (2010)
    Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall
    Int J Radiat Oncol Biol Phys, 81 (5), 1359-66
    DOI 10.1016/j.ijrobp.2010.07.037, PubMed 20933339
  6. König M, Mork J, Hall KS, Osnes T, Meling TR (2010)
    Multimodal treatment of osteogenic sarcoma of the jaw
    Skull Base, 20 (3), 207-12
    DOI 10.1055/s-0029-1246221, PubMed 21318040
  7. Lagunova Z, Porojnicu AC, Grant WB, Bruland Ø, Moan JE (2010)
    Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?
    Mol Nutr Food Res, 54 (8), 1127-33
    DOI 10.1002/mnfr.200900512, PubMed 20512788
  8. Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
    Seasonal variations of cancer incidence and prognosis
    Dermatoendocrinol, 2 (2), 55-7
    DOI 10.4161/derm.2.2.12664, PubMed 21547098
  9. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2010)
    DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
    Acta Oncol, 50 (1), 148-50
    DOI 10.3109/0284186X.2010.516273, PubMed 21110775

Publications 2009

  1. Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
    Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
    Prostate Cancer Prostatic Dis, 12 (3), 269-76
    DOI 10.1038/pcan.2009.8, PubMed 19290019
  2. Brandal P, Bjerkehagen B, Bruland OS, Skjeldal S, Bogsrud TV, Hall KS (2009)
    Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience
    Acta Oncol, 48 (8), 1165-72
    DOI 10.3109/02841860903032809, PubMed 19863225
  3. Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestøl K, Smeland S, Danielsen HE, Mertens F, Lothe RA (2009)
    Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
    Neuro Oncol, 11 (5), 514-28
    DOI 10.1215/15228517-2008-127, PubMed 19182148
  4. Bruland ØS, Bauer H, Alvegaard T, Smeland S (2009)
    Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience
    Cancer Treat Res, 152, 309-18
    DOI 10.1007/978-1-4419-0284-9_16, PubMed 20213398
  5. Bruland ØS, Høifødt H, Hall KS, Smeland S, Fodstad Ø (2009)
    Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients
    Cancer Treat Res, 152, 509-15
    DOI 10.1007/978-1-4419-0284-9_30, PubMed 20213412
  6. Hall KS, Eriksson M, Bruland OS, Engellau J, Trovik CS (2009)
    Treatment of soft tissue sarcoma of the extremity and trunk wall The Scandinavian Sarcoma Group perspective
    Acta Orthop., 80 334, 52-59
  7. Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS (2009)
    Small round cell sarcomas
    Semin Oncol, 36 (4), 338-46
    DOI 10.1053/j.seminoncol.2009.06.006, PubMed 19664494
  8. Norum OJ, Bruland ØS, Gorunova L, Berg K (2009)
    Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model
    Int J Radiat Oncol Biol Phys, 75 (3), 878-85
    DOI 10.1016/j.ijrobp.2009.04.039, PubMed 19665318
  9. Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
    Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
    Anticancer Res, 29 (11), 4331-6
    PubMed 20032375
  10. Sande TA, Ruenes R, Lund JA, Bruland OS, Hornslien K, Bremnes R, Kaasa S (2009)
    Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial
    Radiother Oncol, 91 (2), 261-6
    DOI 10.1016/j.radonc.2009.02.014, PubMed 19307034
  11. Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S (2009)
    The role of radiotherapy in oseosarcoma
    Cancer Treat Res, 152, 147-64
    DOI 10.1007/978-1-4419-0284-9_7, PubMed 20213389
  12. Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Bjork O, Alvegaard TA (2009)
    Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
    Acta Orthop., 80 334, 60-66
  13. Smeland S, Wiebe T, Monge OR, Brosjo O, Bohling T, Hjorth L, Hall KS, Jakobson A, Alvegaard TA (2009)
    Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
    Acta Orthop., 80, 75-78
  14. Søvik S, Skogmo HK, Andersen EK, Bruland ØS, Olsen DR, Malinen E (2009)
    DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis
    Radiother Oncol, 93 (3), 618-24
    DOI 10.1016/j.radonc.2009.08.012, PubMed 19747746

Publications 2008

  1. Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
    Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
    Prostate, 68 (15), 1607-14
    DOI 10.1002/pros.20826, PubMed 18655095
  2. Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
    Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
    Acta Oncol, 47 (8), 1475-82
    DOI 10.1080/02841860802047387, PubMed 18607853
  3. Bruland OS, Jonasdottir TJ, Fisher DR, Larsen RH (2008)
    Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
    Curr. Radiopharm., 1 (3), 203-208
    DOI 10.2174/1874471010801030203
  4. Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2008)
    Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
    J Clin Oncol, 27 (3), 334-43
    DOI 10.1200/JCO.2007.15.3130, PubMed 19075285
  5. Dahle J, Bruland OS, Larsen RH (2008)
    Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
    Int J Radiat Oncol Biol Phys, 72 (1), 186-92
    DOI 10.1016/j.ijrobp.2008.05.029, PubMed 18722269
  6. Erikson A, Tufto I, Bjønnum AB, Bruland ØS, Davies Cde L (2008)
    The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules
    Anticancer Res, 28 (6A), 3557-66
    PubMed 19189635
  7. Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegård T, Bruland OS (2008)
    Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study
    Int J Radiat Oncol Biol Phys, 71 (4), 1196-203
    DOI 10.1016/j.ijrobp.2007.11.023, PubMed 18207661
  8. Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD (2008)
    [Gonadal function after cancer treatment in adult men]
    Tidsskr Nor Laegeforen, 128 (4), 461-5
    PubMed 18274582
  9. Porojnicu AC, Bruland OS, Aksnes L, Grant WB, Moan J (2008)
    Sun beds and cod liver oil as vitamin D sources
    J Photochem Photobiol B, 91 (2-3), 125-31
    DOI 10.1016/j.jphotobiol.2008.02.007, PubMed 18417354
  10. Søvik A, Kippenes Skogmo H, Bruland ØS, Rune Olsen D, Malinen E (2008)
    DCEMRI monitoring of canine tumors during fractionated radiotherapy
    Acta Oncol, 47 (7), 1249-56
    DOI 10.1080/02841860802244166, PubMed 18618342
  11. Vågane R, Bruland ØS, Fosså SD, Olsen DR (2008)
    Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation
    Acta Oncol, 47 (2), 248-54
    DOI 10.1080/02841860701630267, PubMed 18210300

Publications 2007

  1. Aksnes LH, Bruland ØS (2007)
    Some musculo-skeletal sequelae in cancer survivors
    Acta Oncol, 46 (4), 490-6
    DOI 10.1080/02841860701218642, PubMed 17497316
  2. Aksnes LH, Hall KS, Jebsen N, Fosså SD, Dahl AA (2007)
    Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
    Support Care Cancer, 15 (9), 1087-96
    DOI 10.1007/s00520-007-0227-x, PubMed 17347843
  3. Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
    Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
    Int J Cancer, 120 (8), 1603-9
    DOI 10.1002/ijc.22488, PubMed 17230512
  4. Berg A, Lilleby W, Bruland OS, Fosså SD (2007)
    10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
    Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
    DOI 10.1016/j.ijrobp.2007.04.031, PubMed 17703896
  5. Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH (2007)
    Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate
    Blood, 110 (6), 2049-56
    DOI 10.1182/blood-2007-01-066803, PubMed 17536011
  6. Larsen RH, Borrebaek J, Dahle J, Melhus KB, Krogh C, Valan MH, Bruland OS (2007)
    Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding ability
    Cancer Biother Radiopharm, 22 (3), 431-7
    DOI 10.1089/cbr.2006.321, PubMed 17651051
  7. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, Yachnin J, Garkavij M, Strang P, Harmenberg J, Bolstad B, Bruland OS (2007)
    Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
    Lancet Oncol, 8 (7), 587-94
    DOI 10.1016/S1470-2045(07)70147-X, PubMed 17544845
  8. Olsen DR, Bruland OS, Frykholm G, Norderhaug IN (2007)
    Proton therapy - a systematic review of clinical effectiveness
    Radiother Oncol, 83 (2), 123-32
    DOI 10.1016/j.radonc.2007.03.001, PubMed 17499374
  9. Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J (2007)
    Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Lung Cancer, 55 (3), 263-70
    DOI 10.1016/j.lungcan.2006.11.013, PubMed 17207891
  10. Søvik A, Malinen E, Skogmo HK, Bentzen SM, Bruland OS, Olsen DR (2007)
    Radiotherapy adapted to spatial and temporal variability in tumor hypoxia
    Int J Radiat Oncol Biol Phys, 68 (5), 1496-504
    DOI 10.1016/j.ijrobp.2007.04.027, PubMed 17674980

Publications 2006

  1. Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taksdal I, Winderen M, Bruland OS, Saeter G (2006)
    Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience
    Acta Oncol, 45 (1), 38-46
    DOI 10.1080/02841860500466624, PubMed 16464794
  2. Bruland ØS (2006)
    [Jumping after the Swedes]
    Tidsskr Nor Laegeforen, 126 (5), 637
    PubMed 16505887
  3. Bruland ØS, Nilsson S, Fisher DR, Larsen RH (2006)
    High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    Clin Cancer Res, 12 (20 Pt 2), 6250s-6257s
    DOI 10.1158/1078-0432.CCR-06-0841, PubMed 17062709
  4. Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH (2006)
    Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy
    Nucl Med Biol, 33 (2), 271-9
    DOI 10.1016/j.nucmedbio.2005.12.004, PubMed 16546683
  5. Jonasdottir TJ, Fisher DR, Borrebaek J, Bruland OS, Larsen RH (2006)
    First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent
    Anticancer Res, 26 (4B), 2841-8
    PubMed 16886603
  6. Larsen RH, Saxtorph H, Skydsgaard M, Borrebaek J, Jonasdottir TJ, Bruland OS, Klastrup S, Harling R, Ramdahl T (2006)
    Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematology
    In Vivo, 20 (3), 325-31
    PubMed 16724665
  7. Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L (2006)
    Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference
    Clin Cancer Res, 12 (20 Pt 2), 6209s-6212s
    DOI 10.1158/1078-0432.CCR-06-1213, PubMed 17062702
  8. Malinen E, Søvik A, Hristov D, Bruland ØS, Olsen DR (2006)
    Adapting radiotherapy to hypoxic tumours
    Phys Med Biol, 51 (19), 4903-21
    DOI 10.1088/0031-9155/51/19/012, PubMed 16985278
  9. Søvik A, Malinen E, Bruland ØS, Bentzen SM, Olsen DR (2006)
    Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study
    Phys Med Biol, 52 (2), 499-513
    DOI 10.1088/0031-9155/52/2/013, PubMed 17202629

Publications 2005

  1. Brustugun OT, Reed W, Poulsen JP, Bruland OS (2005)
    Primary osteosarcoma of the breast
    Acta Oncol, 44 (7), 767-70
    DOI 10.1080/02841860500254897, PubMed 16227171
  2. Dale E, Hellebust TP, Bruland ØS, Olsen DR (2005)
    Comparative analyses of the dynamic properties of the bladder wall studied by repetitive pelvic CT scans of patients and cryo-sections of cadavers
    Br J Radiol, 78 (930), 528-32
    DOI 10.1259/bjr/82990907, PubMed 15900058
  3. Eikenes L, Tari M, Tufto I, Bruland OS, de Lange Davies C (2005)
    Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts
    Br J Cancer, 93 (1), 81-8
    DOI 10.1038/sj.bjc.6602626, PubMed 15942637
  4. Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R (2005)
    Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
    J Natl Cancer Inst Monogr (34), 77-82
    DOI 10.1093/jncimonographs/lgi019, PubMed 15784830
  5. Henriksen G, Bruland OS, Larsen RH (2005)
    Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies
    Anticancer Res, 25 (1A), 9-15
    PubMed 15816513
  6. Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD (2005)
    Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
    Eur Urol, 48 (5), 779-85
    DOI 10.1016/j.eururo.2005.05.002, PubMed 15963629
  7. Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005)
    First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
    Clin Cancer Res, 11 (12), 4451-9
    DOI 10.1158/1078-0432.CCR-04-2244, PubMed 15958630
  8. Norum J, Bruland ØS, Spanne O, Bergmo T, Green T, Olsen DR, Olsen JH, Sjåeng EE, Burkow T (2005)
    Telemedicine in radiotherapy: a study exploring remote treatment planning, supervision and economics
    J Telemed Telecare, 11 (5), 245-50
    DOI 10.1258/1357633054471858, PubMed 16035967
  9. Onda M, Bruland ØS, Pastan I (2005)
    TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma
    Clin Orthop Relat Res (430), 142-8
    DOI 10.1097/01.blo.0000137544.30200.b6, PubMed 15662316

Publications 2004

  1. Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
    Human osteosarcoma xenografts and their sensitivity to chemotherapy
    Pathol Oncol Res, 10 (3), 133-41
    DOI 10.1007/BF03033741, PubMed 15448748
  2. Eikenes L, Bruland ØS, Brekken C, Davies Cde L (2004)
    Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts
    Cancer Res, 64 (14), 4768-73
    DOI 10.1158/0008-5472.CAN-03-1472, PubMed 15256445
  3. Engellau J, Anderson H, Rydholm A, Bauer HC, Hall KS, Gustafson P, Akerman M, Meis-Kindblom J, Alvegård TA, Nilbert M, Scandinavian Sarcoma Group (2004)
    Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas
    Cancer, 100 (10), 2233-9
    DOI 10.1002/cncr.20254, PubMed 15139069
  4. Fosså SD, Magelssen H (2004)
    Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer
    Ann Oncol, 15 Suppl 4, iv259-65
    DOI 10.1093/annonc/mdh936, PubMed 15477318
  5. Henriksen G, Bruland OS, Larsen RH (2004)
    Thorium and actinium polyphosphonate compounds as bone-seeking alpha particle-emitting agents
    Anticancer Res, 24 (1), 101-5
    PubMed 15015582
  6. Henriksen G, Schoultz BW, Michaelsen TE, Bruland ØS, Larsen RH (2004)
    Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides
    Nucl Med Biol, 31 (4), 441-9
    DOI 10.1016/j.nucmedbio.2003.11.004, PubMed 15093814
  7. Mikkelsen IM, Løkke C, Flagstad T, Bruland ØS (2004)
    Interferon-γ Sensitises Human Osteosarcoma Cells to Trail-mediated Apoptosis
    Cancer Genomics Proteomics, 1 (2), 95-104
    PubMed 31394674
  8. Schoemaker NE, Kuppens IE, Moiseyenko V, Glimelius B, Kjaer M, Starkhammer H, Richel DJ, Smaaland R, Bertelsen K, Poulsen JP, Voznyi E, Norum J, Fennelly D, Tveit KM, Garin A, Gruia G, Mourier A, Sibaud D, Lefebvre P, Beijnen JH, Schellens JH, ten Bokkel Huinink WW (2004)
    A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
    Br J Cancer, 91 (8), 1434-41
    DOI 10.1038/sj.bjc.6602172, PubMed 15381932

Publications 2003

  1. Dale E, Hellebust TP, Bruland ØS, Olsen DR (2003)
    Comparative analyses of the dynamic properties of the rectum studied by cryo-sections of human cadavers and pelvic CT scans of patients
    Br J Radiol, 76 (902), 104-8
    DOI 10.1259/bjr/75640835, PubMed 12642278
  2. Dueland S, Guren MG, Olsen DR, Poulsen JP, Magne Tveit K (2003)
    Radiation therapy induced changes in male sex hormone levels in rectal cancer patients
    Radiother Oncol, 68 (3), 249-53
    DOI 10.1016/s0167-8140(03)00120-8, PubMed 13129632
  3. Guren MG, Dueland S, Skovlund E, Fosså SD, Poulsen JP, Tveit KM (2003)
    Quality of life during radiotherapy for rectal cancer
    Eur J Cancer, 39 (5), 587-94
    DOI 10.1016/s0959-8049(02)00741-4, PubMed 12628837
  4. Henriksen G, Fisher DR, Roeske JC, Bruland ØS, Larsen RH (2003)
    Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice
    J Nucl Med, 44 (2), 252-9
    PubMed 12571218
  5. Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, Ohlsson C, Bruland OS, Gautvik KM (2003)
    Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning
    Anticancer Res, 23 (3B), 2201-16
    PubMed 12894494

Publications 2002

  1. Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS (2002)
    High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
    J Clin Oncol, 20 (1), 189-96
    DOI 10.1200/JCO.2002.20.1.189, PubMed 11773169
  2. Aurlien E, Kvinnsland Y, Larsen RH, Bruland ØS (2002)
    Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro. Comparison of an alpha-emitting radioimmunoconjugate and external gamma-irradiation
    Int J Radiat Biol, 78 (2), 133-42
    DOI 10.1080/09553000110094788, PubMed 11779363
  3. Henriksen G, Breistøl K, Bruland ØS, Fodstad Ø, Larsen RH (2002)
    Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model
    Cancer Res, 62 (11), 3120-5
    PubMed 12036923
  4. Jakobsen A, Berglund A, Glimelius B, Frödin JE, Hansen F, Kjaer M, Madsen EL, Sandberg E, Poulsen JP, Carlsson G, Gustavsson B, Nordic Gastrointestinal Tumour Therapy Group, Norway, Sweden and Denmark (2002)
    Dose-effect relationship of bolus 5-fluorouracil in the treatment of advanced colorectal cancer
    Acta Oncol, 41 (6), 525-31
    DOI 10.1080/02841860214959, PubMed 12546525
  5. Kvinnsland Y, Bruland O, Moe L, Skretting A (2002)
    A method for measurement of the uptake patterns of two beta-emitting radionuclides in the same tissue section with a digital silicon detector: application to a study of 89SrCl2 and 153Sm-EDTMP in a dog with spontaneous osteosarcoma
    Eur J Nucl Med Mol Imaging, 29 (2), 191-7
    DOI 10.1007/s00259-001-0693-1, PubMed 11926381
  6. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
    Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
    Anticancer Res, 22 (4), 1949-57
    PubMed 12174869
  7. Saeter G, Hall KS, Bruland ØS, Solheim ØP, Høie J, Follerås G, Helgerud P, Stenwig AE, Bjerkehagen B, Talle K, Taksdal I, Winderen M (2002)
    [Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]
    Tidsskr Nor Laegeforen, 122 (21), 2089-94
    PubMed 12555642
  8. Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE (2002)
    Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer
    Eur J Surg, 168 (1), 42-8
    DOI 10.1080/110241502317307562, PubMed 12022371
  9. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE (2002)
    Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study
    Radiother Oncol, 62 (2), 207-13
    DOI 10.1016/s0167-8140(01)00486-8, PubMed 11937248

Publications 2001

  1. Hassfjell S, Ingebrigtsen K, Bruland ØS (2001)
    Synthesis, purification and biodistribution of (205)Bi-DOTMP, visualizing bone deposition patterns with autoradiography
    Nucl Med Biol, 28 (4), 425-33
    DOI 10.1016/s0969-8051(01)00202-5, PubMed 11395316
  2. Kvinnsland Y, Skretting A, Bruland OS (2001)
    Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular bone
    Phys Med Biol, 46 (4), 1149-61
    DOI 10.1088/0031-9155/46/4/317, PubMed 11324957
  3. Onda M, Olafsen T, Tsutsumi Y, Bruland OS, Pastan I (2001)
    Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated Pseudomonas exotoxin A
    J Immunother, 24 (2), 144-50
    DOI 10.1097/00002371-200103000-00009, PubMed 11265772

Publications 2000

  1. Aurlien E, Larsen RH, Akabani G, Olsen DR, Zalutsky MR, Bruland OS (2000)
    Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry
    Int J Radiat Biol, 76 (8), 1129-41
    DOI 10.1080/09553000050111604, PubMed 10947126
  2. Aurlien E, Larsen RH, Kvalheim G, Bruland OS (2000)
    Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells
    Br J Cancer, 83 (10), 1375-9
    DOI 10.1054/bjoc.2000.1453, PubMed 11044364
  3. Braendengen M, Bruland OS, Olsen DR (2000)
    [Radiotherapy of skeletal metastases]
    Tidsskr Nor Laegeforen, 120 (16), 1870-4
    PubMed 10925615
  4. Brekken C, Bruland ØS, de Lange Davies C (2000)
    Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase
    Anticancer Res, 20 (5B), 3503-12
    PubMed 11131654
  5. Brekken C, Hjelstuen MH, Bruland ØS, de Lange Davies C (2000)
    Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts
    Anticancer Res, 20 (5B), 3513-9
    PubMed 11131655
  6. Pihl A, Bruland OS (2000)
    Oral presentations in science and medicine. An art in decline?
    Anticancer Res, 20 (5A), 2795-9
    PubMed 11062686
  7. Wiig JN, Poulsen JP, Tveit KM, Olsen DR, Giercksky KE (2000)
    Intra-operative irradiation (IORT) for primary advanced and recurrent rectal cancer. a need for randomised studies
    Eur J Cancer, 36 (7), 868-74
    DOI 10.1016/s0959-8049(00)00015-0, PubMed 10785591

Publications 1999

  1. Jemtland R, Rian E, Olstad OK, Haug E, Bruland OS, Bucht E, Gautvik KM (1999)
    Two human osteoblast-like osteosarcoma cell lines show distinct expression and differential regulation of parathyroid hormone-related protein
    J Bone Miner Res, 14 (6), 904-14
    DOI 10.1359/jbmr.1999.14.6.904, PubMed 10352098
  2. Larsen RH, Murud KM, Akabani G, Hoff P, Bruland OS, Zalutsky MR (1999)
    211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation
    J Nucl Med, 40 (7), 1197-203
    PubMed 10405142
  3. Murud KM, Larsen RH, Bruland OS, Hoff P (1999)
    Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of 211At and 125I-labeled amidobisphosphonates in mice
    Nucl Med Biol, 26 (7), 791-4
    DOI 10.1016/s0969-8051(99)00047-5, PubMed 10628558
  4. Norum LF, Poulsen JP, Ruud TE, Giercksky KE, Røkke O (1999)
    [Abdominal metastases from signet cell carcinoma of the appendix vermiformis]
    Tidsskr Nor Laegeforen, 119 (3), 371-2
    PubMed 10074833
  5. Olafsen T, Munthe Lund CK, Bruland OS, Sandlie I, Michaelsen TE (1999)
    Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies
    Cancer Immunol Immunother, 48 (7), 411-8
    DOI 10.1007/s002620050594, PubMed 10501855
  6. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O (1999)
    Expression of a novel factor in human breast cancer cells with metastatic potential
    Cancer Res, 59 (18), 4675-80
    PubMed 10493524
  7. Tanum G, Bruland OS, Hjelle D, Reitan JB (1999)
    [Patient treatment in radiation accidents]
    Tidsskr Nor Laegeforen, 119 (10), 1446-50
    PubMed 10354753
  8. Aas M, Moe L, Gamlem H, Skretting A, Ottesen N, Bruland OS (1999)
    Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP)
    Clin Cancer Res, 5 (10 Suppl), 3148s-3152s
    PubMed 10541356

Publications 1998

  1. Hassfjell SP, Skretting A, Bruland OS, Hoff P (1998)
    Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals
    Nucl Med Commun, 19 (3), 207-17
    DOI 10.1097/00006231-199803000-00004, PubMed 9625495
  2. Helle SI, Geisler J, Poulsen JP, Hestdal K, Meadows K, Collins W, Tveit KM, Holly JM, Lønning PE (1998)
    Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study
    Br J Cancer, 78 (1), 14-20
    DOI 10.1038/bjc.1998.435, PubMed 9662244
  3. Larsen RH, Bruland OS (1998)
    Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay
    Br J Cancer, 77 (7), 1115-22
    DOI 10.1038/bjc.1998.185, PubMed 9569048
  4. Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, Sobrinho-Simões M, Nesland JM (1998)
    Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers
    Anal Cell Pathol, 16 (1), 45-62
    DOI 10.1155/1998/545906, PubMed 9584899
  5. Olafsen T, Rasmussen IB, Norderhaug L, Bruland OS, Sandlie I (1998)
    IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells
    Immunotechnology, 4 (2), 141-53
    DOI 10.1016/s1380-2933(98)00014-1, PubMed 9853955
  6. Olsen DR, Bruland OS (1998)
    Radiotherapy in Scandinavia
    Acta Oncol, 37 (6), 553-60
    DOI 10.1080/028418698430250, PubMed 9860313

Publications 1997

  1. Bruland OS, Pihl A (1997)
    On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy
    Eur J Cancer, 33 (11), 1725-31
    DOI 10.1016/s0959-8049(97)00252-9, PubMed 9470825
  2. Ekstrøm PO, Giercksky KE, Andersen A, Bruland OS, Slørdal L (1997)
    Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis
    Life Sci, 61 (19), PL275-80
    DOI 10.1016/s0024-3205(97)00839-4, PubMed 9364204
  3. Hassfjell SP, Bruland OS, Hoff P (1997)
    212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy
    Nucl Med Biol, 24 (3), 231-7
    DOI 10.1016/s0969-8051(97)00059-0, PubMed 9228657
  4. Lopes JM, Bruland OS, Bjerkehagen B, Silva MC, Holm R, Pettersen EO, Solheim OP, Sobrinho-Simões M, Nesland JM (1997)
    Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance
    Pathol Res Pract, 193 (1), 21-36
    DOI 10.1016/s0344-0338(97)80090-8, PubMed 9112270
  5. Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE (1997)
    Combined modality treatment including IORT in locally advanced and recurrent rectal cancer: results from a prospective Norwegian study
    Front Radiat Ther Oncol, 31, 221-3
    DOI 10.1159/000061129, PubMed 9263827
  6. Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE (1997)
    Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer
    Radiother Oncol, 44 (3), 277-82
    DOI 10.1016/s0167-8140(97)00070-4, PubMed 9380828

Publications 1996

  1. Bruland OS, Skretting A, Solheim OP, Aas M (1996)
    Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach
    Acta Oncol, 35 (3), 381-4
    DOI 10.3109/02841869609101655, PubMed 8679270
  2. Gordeladze JO, Lund HW, Jablonski G, Bruland OS (1996)
    Diverse expression of G-proteins in human sarcoma cell lines with different osteogenic potential: evidence for the involvement of Gi2 in cell proliferation
    J Cell Biochem, 60 (1), 95-106
    DOI 10.1002/(SICI)1097-4644(19960101)60:1%3C95::AID-JCB12%3E3.0.CO;2-J, PubMed 8825419
  3. Moe L, Boysen M, Aas M, Lønaas L, Gamlem H, Bruland OS (1996)
    Maxillectomy and targeted radionuclide therapy with 153Sm-EDTMP in a recurrent canine osteosarcoma
    J Small Anim Pract, 37 (5), 241-6
    DOI 10.1111/j.1748-5827.1996.tb01782.x, PubMed 8736231
  4. Olafsen T, Bruland OS, Zalutsky MR, Sandlie I (1996)
    Abundant tyrosine residues in the antigen binding site in anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Application to radiolabeling
    Acta Oncol, 35 (3), 297-301
    DOI 10.3109/02841869609101644, PubMed 8679259
  5. Saeter G, Bruland OS, Follerås G, Boysen M, Høie J (1996)
    Extremity and non-extremity high-grade osteosarcoma -- the Norwegian Radium Hospital experience during the modern chemotherapy era
    Acta Oncol, 35 Suppl 8, 129-34
    DOI 10.3109/02841869609098531, PubMed 9073059

Publications 1995

  1. Larsen RH, Hoff P, Vergote IB, Bruland OS, Aas M, De Vos L, Nustad K (1995)
    Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model
    Gynecol Oncol, 57 (1), 9-15
    DOI 10.1006/gyno.1995.1093, PubMed 7705707
  2. Olafsen T, Bruland OS, Zalutsky MR, Sandlie I (1995)
    Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabeling
    Nucl Med Biol, 22 (6), 765-71
    DOI 10.1016/0969-8051(95)00014-o, PubMed 8535337

Publications 1994

  1. Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK (1994)
    Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays
    Radiat Res, 139 (2), 178-84
    DOI 10.2307/3578662, PubMed 8052693
  2. Larsen RH, Bruland OS, Hoff P, Alstad J, Rofstad EK (1994)
    Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody
    Br J Cancer, 69 (6), 1000-5
    DOI 10.1038/bjc.1994.196, PubMed 8198960
  3. Page RL, Garg PK, Garg S, Archer GE, Bruland OS, Zalutsky MR (1994)
    PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment
    J Nucl Med, 35 (9), 1506-13
    PubMed 8071702

Publications 1993

  1. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
    p53 abnormalities in different subtypes of human sarcomas
    Cancer Res, 53 (3), 468-71
    PubMed 8425179

Publications 1992

  1. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992)
    Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
    Cancer Res, 52 (21), 6088-91
    PubMed 1356624
  2. Fosså SD, Poulsen JP, Aaserud A (1992)
    Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer
    Lancet, 340 (8834-8835), 1544
    DOI 10.1016/0140-6736(92)92794-g, PubMed 1281904
  3. Haines DM, Bruland OS, Matte G, Wilkinson AA, Meric SM, Fowler JD (1992)
    Immunoscintigraphic detection of primary and metastatic spontaneous canine osteosarcoma with F(ab')2 fragments of osteosarcoma-associated monoclonal antibody TP-1
    Anticancer Res, 12 (6B), 2151-7
    PubMed 1295462
  4. Hansen TW, Poulsen JP, Bratlid D (1992)
    The effects of hypoxanthine, xanthine oxidase and hyperoxia on the accumulation of bilirubin and albumin in young rat brain
    Early Hum Dev, 30 (2), 171-7
    DOI 10.1016/0378-3782(92)90144-6, PubMed 1493769

Publications 1990

  1. Fjeld JG, Bruland OS, Benestad HB, Schjerven L, Stigbrand T, Nustad K (1990)
    Radioimmunotargeting of human tumour cells in immunocompetent animals
    Br J Cancer, 62 (4), 573-8
    DOI 10.1038/bjc.1990.332, PubMed 2223574

Publications 1989

  1. Haines DM, Bruland OS (1989)
    Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcoma
    Anticancer Res, 9 (4), 903-7
    PubMed 2684000
  2. Scheuch CH, Berndt CH, Gross J, Poulsen JP, Saugstad DO, Haberland A (1989)
    Influence of the hypoxanthine/xanthine oxidase system on striatal (3H) dopamine uptake
    Biomed Biochim Acta, 48 (2-3), S212-6
    PubMed 2730611

Publications 1982

  1. Ibsen KK, Hansen B, Jensen J, Klebak S, Merrick J, Michelsen N, Poulsen JP, Uldall P, Zachau-Christiansen B (1982)
    [Social pediatrics in Denmark today]
    Ugeskr Laeger, 144 (1), 48-53
    PubMed 7064246

Publications 1979

  1. Sørensen K, Nielsen J, Busch P, Hamborg-Petersen B, Hansen E, Lassen LB, Nielsen K, Poulsen JP, Rossen K, Schaap SK, Taudorf K, Thelle T, Vestermark S, Vrang C (1979)
    [Measurement of testicular volume with Prader's orchiometer in 1,389 boys 5--15 1/2 years old]
    Ugeskr Laeger, 141 (14), 915-8
    PubMed 425192
 
Page visits: 9929